Agilent (A) Completes Genohm Buyout, Strengthens Portfolio

Credit: Shutterstock photo

Agilent Technologies Inc.A recently announced that it successfully closed the acquisition of Switzerland-based Genohm on May 14. The financial details of the acquisition have been kept confidential.

The company recently announced fiscal second-quarter results on May 14. Following the announcement, the company's share price fell 10%. Also, shares of Agilent have slightly underperformed its industry in the 12-month period. The stock has returned 9.99% compared with the industry 's gain of 17.94%.

Deal Details

As revealed, Genohm provides cloud-based solutions to digitize its customers' lab workflow. Its main laboratory software automation suite, SLIMS is a digital platform that provides laboratories with laboratory information management system (LIMS) and electronic lab notebook (ELN) environment.

This automation software is mostly used in biobanks, research labs and next-gen sequencing facilities.

The acquisition will allow Agilent to widen its growth prospects, and further expand its software portfolio by adding LIMS and workflow management. It complements Agilent's own sales efforts and will help it to offer better services to its customers.

Acquisitions - Key Catalyst

Since the past few years, strategic acquisitions have been playing an important role in shaping Agilent's growth trajectory. The buyouts of Lasergen (April 2018), Advanced Analytical Technologies (March 2018), Multiplicom NV (January 2017), Cobalt Light Systems (July 2017), Seahorse Bioscience and iLab Solutions (2016) has expanded its product portfolio.

The deal acquiring Advanced Analytical Technologies expanded Agilent's capillary electrophoresis solutions portfolio. Multiplicom deal expanded Agilent's genetic testing technology and product offerings. The Cobalt deal strengthened the company's presence in the high-growth Raman spectroscopy market. The acquisition of iLab Solutions enabled the company to provide cloud-based laboratory management software.

We remain optimistic about Agilent's broad-based portfolio and increased focus on the segments with higher growth potential.

Agilent Technologies, Inc. Price and Consensus

Agilent Technologies, Inc. Price and Consensus | Agilent Technologies, Inc. Quote

Zacks Rank & Stocks to Consider

Agilent has a Zacks Rank #3 (Hold). Other top-ranked stocks in the technology sector are Littelfuse, Inc. LFUS , sporting a Zacks Rank #1 (Strong Buy), while SMC Corporation SMCAY and, Inc. AMZN , both carrying a Zacks Rank #2. You can see the complete list of today's Zacks #1 Rank stocks here .

Long-term earnings per share growth rate for Littelfuse, Amazon and SMC Corporation is projected at 12%, 30.2% and 13.7%, respectively.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +21.9% in 2017, our top stock-picking screens have returned +115.0%, +109.3%, +104.9%, +98.6%, and +67.1%.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - 2017, the composite yearly average gain for these strategies has beaten the market more than 19X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report, Inc. (AMZN): Free Stock Analysis Report

Littelfuse, Inc. (LFUS): Free Stock Analysis Report

Agilent Technologies, Inc. (A): Free Stock Analysis Report

Smc Corporation (SMCAY): Free Stock Analysis Report

To read this article on click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

Learn More